Three faculty members awarded the 2018 CAME Certificate of Merit Award
This award promotes, recognizes and rewards faculty committed to medical education in Canadian medical schools.
An unexpected target — and weapon — for one of the deadliest cancers
A new drug, fostamatinib, reduced the growth rate of esophageal adenocarcinoma in mice by at least 70 per cent.
Genetics Society of America honours Philip Hieter with the 2018 George W. Beadle Award
This award honours individuals who have made outstanding contributions to the community of researchers in the field of genetics.
47 members of the Faculty receive latest CIHR Project Grants competition
A total of $43M was awarded to UBC researchers for 65 projects at the university and its affiliated health authority research centres.
Use of fentanyl signals limits of substitution therapy for many Downtown Eastside residents
The study of people living in marginal housing also showed how quickly fentanyl infiltrated the community in 2017.
Indigenous people face higher risk of transportation injuries in B.C.
Overall hospitalization rates for transport injuries in B.C. declined by more than two-thirds between 1991 and 2010.
Four faculty members win UBC’s 2017 Faculty Research Awards
Four members of the Faculty of Medicine are being recognized by UBC’s Faculty Research Awards. Winners of these awards were selected by UBC’s Faculty Research Award Committee, which spans arts and humanities, business, education, applied science, science and medicine.
UBC-developed drug shows promise for calming overeager stem cells
The drug stops stem cells from differentiating too early and too quickly.
UBC Medicine receives 40% of national genomics funding
The 10 projects, totaling $101 million, include an effort to reduce the risk of kidney transplant rejection.
By jamming a lock, UBC scientists stop cancer cell growth
A team led by Christopher Ong in Urologic Sciences developed a protein-based drug that stops unrestricted cell proliferation. Next step: A clinical trial.